PREVIOUS QUESTION:

 

NEXT QUESTION:

 

What is withdrawal akathisia?

ANSWER

Withdrawal akathisia usually sets in within 6 weeks after you switch or stop an antipsychotic drug.

SOURCES:

Current Psychiatry : “Akathisia: Is restlessness a primary condition or adverse drug effect?”

Psychiatry : “Antipsychotic-Induced Movement Disorders.”

Current Opinions in Psychiatry : “Akathisia and second-generation antipsychotic drugs.”

Medicines and Healthcare Products Regulatory Agency: “Antipsychotics learning module.”

Future Research Needs for First and Second-Generation Antipsychotics for Children and Young Adults : “Appendix A: Tables of FDA-Approved Indications for First- and Second-Generation Antipsychotics.”

Journal of Neurophysiology: “Dopamine triggers skeletal muscle tone by activating D1-like receptors on somatic motoneurons.”

BMJ: “Akathisia: Overlooked at a Cost.”

Movement Disorders : “Akathisia in Parkinson's disease,” “Tardive akathisia: an analysis of clinical features and response to open therapeutic trials.”

Journal of Rehabilitation Research & Development : “Akathisia -- rare cause of psychomotor agitation in patients with traumatic brain injury: Case report and review of literature.”

General Hospital Psychiatry : “Propranolol-responsive akathisia following acute encephalitis.”

Encyclopedia of Movement Disorders : “Akathisia.”

Psychiatric Annals : “Akathisia: Case Presentation and Review of Newer Treatment Agents.”

Desai, A., Grossberg, G. , The Johns Hopkins University Press, 2010. Psychiatric Consultation in Long-Term Care

British Journal of Psychiatry : “A Rating Scale for Drug-Induced Akathisia.”

Outcome Tracker: “Barnes Akathisia Rating Scale (BARS).”

Medscape: “Restless Legs Syndrome Differential Diagnoses.”

National Institutes of Health: “Restless Legs Syndrome Fact Sheet."

Mayo Clinic: “Movement Disorders.”

Journal of the American Medical Association: “Akathisia Variants and Tardive Dyskinesia.”

Cochrane Database system Review: “Anticholinergics for neuroleptic-induced acute akathisia.”

Clinical Neuropharmacology: “ Trazodone for the treatment of neuroleptic-induced acute akathisia: a placebo-controlled, double-blind, crossover study.”

Kaufman, D. Elsevier, 2007. Clinical Neurology for Psychiatrists,

Reviewed by Joseph Goldberg on December 19, 2018

SOURCES:

Current Psychiatry : “Akathisia: Is restlessness a primary condition or adverse drug effect?”

Psychiatry : “Antipsychotic-Induced Movement Disorders.”

Current Opinions in Psychiatry : “Akathisia and second-generation antipsychotic drugs.”

Medicines and Healthcare Products Regulatory Agency: “Antipsychotics learning module.”

Future Research Needs for First and Second-Generation Antipsychotics for Children and Young Adults : “Appendix A: Tables of FDA-Approved Indications for First- and Second-Generation Antipsychotics.”

Journal of Neurophysiology: “Dopamine triggers skeletal muscle tone by activating D1-like receptors on somatic motoneurons.”

BMJ: “Akathisia: Overlooked at a Cost.”

Movement Disorders : “Akathisia in Parkinson's disease,” “Tardive akathisia: an analysis of clinical features and response to open therapeutic trials.”

Journal of Rehabilitation Research & Development : “Akathisia -- rare cause of psychomotor agitation in patients with traumatic brain injury: Case report and review of literature.”

General Hospital Psychiatry : “Propranolol-responsive akathisia following acute encephalitis.”

Encyclopedia of Movement Disorders : “Akathisia.”

Psychiatric Annals : “Akathisia: Case Presentation and Review of Newer Treatment Agents.”

Desai, A., Grossberg, G. , The Johns Hopkins University Press, 2010. Psychiatric Consultation in Long-Term Care

British Journal of Psychiatry : “A Rating Scale for Drug-Induced Akathisia.”

Outcome Tracker: “Barnes Akathisia Rating Scale (BARS).”

Medscape: “Restless Legs Syndrome Differential Diagnoses.”

National Institutes of Health: “Restless Legs Syndrome Fact Sheet."

Mayo Clinic: “Movement Disorders.”

Journal of the American Medical Association: “Akathisia Variants and Tardive Dyskinesia.”

Cochrane Database system Review: “Anticholinergics for neuroleptic-induced acute akathisia.”

Clinical Neuropharmacology: “ Trazodone for the treatment of neuroleptic-induced acute akathisia: a placebo-controlled, double-blind, crossover study.”

Kaufman, D. Elsevier, 2007. Clinical Neurology for Psychiatrists,

Reviewed by Joseph Goldberg on December 19, 2018

NEXT QUESTION:

How is akathisia diagnosed?

WAS THIS ANSWER HELPFUL

"ALEXA, ASK WEBMD"

THIS TOOL DOES NOT PROVIDE MEDICAL ADVICE. It is intended for general informational purposes only and does not address individual circumstances. It is not a substitute for professional medical advice, diagnosis or treatment and should not be relied on to make decisions about your health. Never ignore professional medical advice in seeking treatment because of something you have read on the WebMD Site. If you think you may have a medical emergency, immediately call your doctor or dial 911.

    This tool does not provide medical advice. See additional information.